Inhibition of MAPK Signaling Pathways by VopA from Vibrio parahaemolyticus
During infection, bacterial pathogens utilize a type III secretion system to inject effectors into the cytoplasm of a target cell where they disrupt the defense system of the host cell. Vibrio parahaemolyticus , a causative agent of gastroenteritis endemic in Southeast Asia, has a type III secretion...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2004-12, Vol.279 (50), p.51953-51957 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | During infection, bacterial pathogens utilize a type III secretion system to inject effectors into the cytoplasm of a target
cell where they disrupt the defense system of the host cell. Vibrio parahaemolyticus , a causative agent of gastroenteritis endemic in Southeast Asia, has a type III secretion system that encodes a novel member
of the YopJ-like protein effector family, VopA ( V ibrio o uter p rotein A). Our studies revealed that Vibrio VopA encodes an evolutionarily conserved activity that is extremely potent and requires an intact catalytic site to abrogate
signaling pathways in a manner distinct from that of other YopJ-like effectors. We observed that VopA efficiently inhibits
the MAPK signaling pathways but not the NFκB pathway in mammalian cells. When expressed in yeast, VopA induces a growth arrest
phenotype and also blocks yeast MAPK signaling pathways. Our observations provide insight into the immense diversity of targets
utilized by YopJ-like effectors to manipulate eukaryotic signaling machineries that are important for the response and survival
of the host cell during infection and/or symbiosis. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M407001200 |